Omics Screening and monitoring Research and Innovations

Laboratory Testing Brings Clarity to Brucellosis

Multimodal testing identifies Brucella abortus across cattle, goats, pigs, and sheep

02/05/2026 News 2 min read

Share

Clinical Scorecard: Laboratory Testing Brings Clarity to Brucellosis

At a Glance

Category	Detail
Condition	Brucellosis
Key Mechanisms	Zoonotic infection affecting livestock and humans, primarily diagnosed through serologic tests.
Target Population	Livestock (cattle, goats, sheep, pigs) and humans in endemic regions.
Care Setting	Low-resource settings, primarily in slaughterhouses.

Key Highlights

B. abortus identified as the only circulating Brucella species in Cameroon.
Estimated prevalence of Brucella infection: 8.3% in cattle, 7.3% in goats.
Culture positivity rate of 0.8% in cattle; PCR increased detection rates.
Serologic tests require careful interpretation; RBT and iELISA improve specificity.
Genomic analysis indicates long-standing regional circulation of B. abortus.

Guideline-Based Recommendations

Diagnosis

Use a combination of serologic tests, culture, and molecular methods for accurate diagnosis.

Management

Implement screening protocols using RBT and iELISA for livestock.

Monitoring & Follow-up

Regularly assess prevalence and species identification through comprehensive testing.

Risks

Serologic tests cannot distinguish between Brucella species; low sensitivity of culture in chronic infections.

Patient & Prescribing Data

Livestock and humans in endemic areas.

Combination of diagnostic methods is crucial for effective management.

Clinical Best Practices

Combine serology with molecular or culture-based methods for accurate species identification.
Validate iELISA assays locally to establish appropriate cutoff values.

Related Resources & Content

Nature Communications Study